BSE Live
Feb 06, 16:01Prev. Close
829.80
Open Price
829.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 06, 15:58Prev. Close
828.95
Open Price
827.05
Bid Price (Qty.)
823.55 (117)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Natco Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 25.33 | 34.98 | 39.26 | 27.89 | 9.14 | |
| Diluted EPS (Rs.) | 25.26 | 34.87 | 39.13 | 27.87 | 9.11 | |
| Cash EPS (Rs.) | 30.65 | 39.64 | 41.27 | 30.91 | 11.87 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 207.95 | 191.29 | 166.72 | 94.75 | 74.75 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 207.95 | 191.29 | 166.72 | 94.75 | 74.75 | |
| Revenue from Operations/Share (Rs.) | 105.22 | 114.77 | 118.42 | 115.77 | 59.90 | |
| PBDIT/Share (Rs.) | 37.91 | 50.68 | 52.51 | 39.96 | 15.82 | |
| PBIT/Share (Rs.) | 32.43 | 46.25 | 48.92 | 36.84 | 12.90 | |
| PBT/Share (Rs.) | 31.25 | 45.19 | 48.09 | 35.78 | 11.58 | |
| Net Profit/Share (Rs.) | 25.17 | 35.20 | 37.68 | 27.79 | 8.95 | |
| NP After MI And SOA / Share (Rs.) | 25.32 | 35.31 | 37.73 | 27.85 | 9.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 36.03 | 44.16 | 44.34 | 34.51 | 26.40 | |
| PBIT Margin (%) | 30.81 | 40.29 | 41.31 | 31.82 | 21.52 | |
| PBT Margin (%) | 29.69 | 39.37 | 40.60 | 30.90 | 19.33 | |
| Net Profit Margin (%) | 23.92 | 30.67 | 31.81 | 24.00 | 14.94 | |
| NP After MI And SOA Margin (%) | 24.06 | 30.76 | 31.86 | 24.05 | 15.07 | |
| Return on Networth/Equity (%) | 12.21 | 18.46 | 22.66 | 29.46 | 12.12 | |
| Return on Capital Employed (%) | 15.12 | 23.61 | 28.90 | 38.01 | 16.88 | |
| Return on Assets (%) | 10.04 | 14.97 | 18.73 | 20.96 | 8.62 | |
| Total Debt/Equity (X) | 0.08 | 0.11 | 0.06 | 0.13 | 0.08 | |
| Asset Turnover Ratio (%) | 0.40 | 48.67 | 58.80 | 87.16 | 57.21 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.39 | 3.22 | 3.60 | 1.74 | 1.70 | |
| Quick Ratio (X) | 2.58 | 2.50 | 2.86 | 1.18 | 0.97 | |
| Inventory Turnover Ratio (X) | 0.62 | 3.96 | 4.98 | 5.79 | 2.92 | |
| Dividend Payout Ratio (NP) (%) | 27.64 | 14.26 | 21.67 | 24.19 | 13.87 | |
| Dividend Payout Ratio (CP) (%) | 22.72 | 12.66 | 19.79 | 21.76 | 10.48 | |
| Earnings Retention Ratio (%) | 72.36 | 85.74 | 78.33 | 75.81 | 86.13 | |
| Cash Earnings Retention Ratio (%) | 77.28 | 87.34 | 80.21 | 78.24 | 89.52 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 32.09 | 43.73 | 58.61 | 34.75 | 9.80 | |
| Interest Coverage Ratios (Post Tax) (%) | 32.09 | 43.73 | 58.61 | 34.75 | 9.80 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 9,473.03 | 10,540.50 | 13,909.21 | 14,970.05 | 7,227.77 | |
| EV/Net Operating Revenue (X) | 4.95 | 5.03 | 6.37 | 7.41 | 6.93 | |
| EV/EBITDA (X) | 13.73 | 11.40 | 14.36 | 21.47 | 26.26 | |
| MarketCap/Net Operating Revenue (X) | 4.81 | 4.98 | 6.37 | 7.32 | 6.88 | |
| Retention Ratios (%) | 72.35 | 85.73 | 78.32 | 75.80 | 86.12 | |
| Price/BV (X) | 2.44 | 2.99 | 4.53 | 8.96 | 5.53 | |
| Price/Net Operating Revenue | 4.81 | 4.98 | 6.37 | 7.32 | 6.88 | |
| Earnings Yield | 0.05 | 0.06 | 0.05 | 0.03 | 0.02 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y